Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD

M. Bartosova, B. Schaefer, K. Vondrak, P. Sallay, C. Taylan, R. Cerkauskiene, M. Dzierzega, G. Milosevski-Lomic, R. Büscher, A. Zaloszyc, P. Romero, F. Lasitschka, BA. Warady, F. Schaefer, A. Ujszaszi, CP. Schmitt,

. 2019 ; 10 (-) : 356. [pub] 20190402

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19029122

The impact of peritoneal dialysis (PD) associated peritonitis on peritoneal membrane integrity is incompletely understood. Children are particularly suited to address this question, since they are largely devoid of preexisting tissue damage and life-style related alterations. Within the International Peritoneal Biobank, 85 standardized parietal peritoneal tissue samples were obtained from 82 children on neutral pH PD fluids with low glucose degradation product (GDP) content. 37 patients had a history of peritonitis and 16 of the 37 had two or more episodes. Time interval between tissue sampling and the last peritonitis episode was 9 (4, 36) weeks. Tissue specimen underwent digital imaging and molecular analyses. Patients with and without peritonitis were on PD for 21.0 (12.0, 36.0) and 12.8 (7.3, 27.0) months (p = 0.053), respectively. They did not differ in anthropometric or histomorphometric parameters [mesothelial coverage, submesothelial fibrosis, blood, and lymphatic vascularization, leukocyte, macrophage and activated fibroblast counts, epithelial-mesenchymal transition (EMT), podoplanin positivity and vasculopathy]. VEGF and TGF-ß induced pSMAD abundance were similar. Similar findings were also obtained after matching for age and PD vintage and a subgroup analysis according to time since last peritonitis (<3, <6, >6 months). In patients with more than 24 months of PD vintage, submesothelial thickness, vessel number per mmm section length and ASMA fibroblast positivity were higher in patients with peritonitis history; only the difference in ASMA positivity persisted in multivariable analyses. While PD duration and EMT were independently associated with submesothelial thickness, and glucose exposure and EMT with peritoneal vessel density in the combined groups, submesothelial thickness was independently associated with EMT in the peritonitis free patients, and with duration of PD in patients with previous peritonitis. This detailed analysis of the peritoneal membrane in pediatric patients on PD with neutral pH, low GDP fluids, does not support the notion of a consistent long-term impact of peritonitis episodes on peritoneal membrane ultrastructure, on inflammatory and fibrotic cell activity and EMT. Peritoneal alterations are mainly driven by PD duration, dialytic glucose exposure, and associated EMT.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19029122
003      
CZ-PrNML
005      
20190815114715.0
007      
ta
008      
190813s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fphys.2019.00356 $2 doi
035    __
$a (PubMed)31001140
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bartosova, Maria $u Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
245    10
$a Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD / $c M. Bartosova, B. Schaefer, K. Vondrak, P. Sallay, C. Taylan, R. Cerkauskiene, M. Dzierzega, G. Milosevski-Lomic, R. Büscher, A. Zaloszyc, P. Romero, F. Lasitschka, BA. Warady, F. Schaefer, A. Ujszaszi, CP. Schmitt,
520    9_
$a The impact of peritoneal dialysis (PD) associated peritonitis on peritoneal membrane integrity is incompletely understood. Children are particularly suited to address this question, since they are largely devoid of preexisting tissue damage and life-style related alterations. Within the International Peritoneal Biobank, 85 standardized parietal peritoneal tissue samples were obtained from 82 children on neutral pH PD fluids with low glucose degradation product (GDP) content. 37 patients had a history of peritonitis and 16 of the 37 had two or more episodes. Time interval between tissue sampling and the last peritonitis episode was 9 (4, 36) weeks. Tissue specimen underwent digital imaging and molecular analyses. Patients with and without peritonitis were on PD for 21.0 (12.0, 36.0) and 12.8 (7.3, 27.0) months (p = 0.053), respectively. They did not differ in anthropometric or histomorphometric parameters [mesothelial coverage, submesothelial fibrosis, blood, and lymphatic vascularization, leukocyte, macrophage and activated fibroblast counts, epithelial-mesenchymal transition (EMT), podoplanin positivity and vasculopathy]. VEGF and TGF-ß induced pSMAD abundance were similar. Similar findings were also obtained after matching for age and PD vintage and a subgroup analysis according to time since last peritonitis (<3, <6, >6 months). In patients with more than 24 months of PD vintage, submesothelial thickness, vessel number per mmm section length and ASMA fibroblast positivity were higher in patients with peritonitis history; only the difference in ASMA positivity persisted in multivariable analyses. While PD duration and EMT were independently associated with submesothelial thickness, and glucose exposure and EMT with peritoneal vessel density in the combined groups, submesothelial thickness was independently associated with EMT in the peritonitis free patients, and with duration of PD in patients with previous peritonitis. This detailed analysis of the peritoneal membrane in pediatric patients on PD with neutral pH, low GDP fluids, does not support the notion of a consistent long-term impact of peritonitis episodes on peritoneal membrane ultrastructure, on inflammatory and fibrotic cell activity and EMT. Peritoneal alterations are mainly driven by PD duration, dialytic glucose exposure, and associated EMT.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Schaefer, Betti $u Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
700    1_
$a Vondrak, Karel $u Department of Pediatrics, Motol University Hospital, Prague, Czechia.
700    1_
$a Sallay, Peter $u 1st Department of Pediatrics, Semmelweis University, Budapest, Hungary.
700    1_
$a Taylan, Christina $u Pediatric Nephrology, Children's and Adolescent's Hospital, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Cerkauskiene, Rimante $u Children's Clinic, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
700    1_
$a Dzierzega, Maria $u Department of Pediatric Emergency, Medicine University Hospital, Polish-American Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
700    1_
$a Milosevski-Lomic, Gordana $u Nephrology Department, University Children's Hospital, Belgrade, Serbia.
700    1_
$a Büscher, Rainer $u Pediatric Nephrology, University Children's Hospital, Essen, Germany.
700    1_
$a Zaloszyc, Ariane $u Department of Pediatrics 1, Strasbourg University Hospital, Strasbourg, France.
700    1_
$a Romero, Philipp $u Division of Pediatric Surgery, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.
700    1_
$a Lasitschka, Felix $u Department of General Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
700    1_
$a Warady, Bradley A $u Children's Mercy Kansas City, Kansas City, MO, United States.
700    1_
$a Schaefer, Franz $u Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
700    1_
$a Ujszaszi, Akos $u Division of Nephrology, University Hospital Heidelberg, Heidelberg, Germany.
700    1_
$a Schmitt, Claus Peter $u Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
773    0_
$w MED00174601 $t Frontiers in physiology $x 1664-042X $g Roč. 10, č. - (2019), s. 356
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31001140 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190815114943 $b ABA008
999    __
$a ind $b bmc $g 1434271 $s 1067582
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 10 $c - $d 356 $e 20190402 $i 1664-042X $m Frontiers in physiology $n Front. physiol. $x MED00174601
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Možnosti archivace